Clinical Trial Update: Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies

View source ↗

Summary

The clinical trial evaluating the SEQureDx Trisomy Test for detecting Down syndrome in low-risk pregnancies has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome

Snippet

Sponsor: Sequenom, Inc. | Conditions: Aneuploidy, Down Syndrome | Status: COMPLETED